Procept Biorobotics Corp Stock Current Valuation
| PRCT Stock | USD 95.59 1.70 1.75% |
Valuation analysis of Procept Biorobotics Corp helps investors to measure Procept Biorobotics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -19.29 in 2024. Enterprise Value Multiple is likely to drop to -19.29 in 2024. Fundamental drivers impacting Procept Biorobotics' valuation include:
Price Book 21.8226 | Enterprise Value 5.1 B | Enterprise Value Ebitda (24.58) | Price Sales 26.3407 | Enterprise Value Revenue 25.7596 |
Overvalued
Today
Please note that Procept Biorobotics' price fluctuation is very steady at this time. Calculation of the real value of Procept Biorobotics Corp is based on 3 months time horizon. Increasing Procept Biorobotics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Procept Biorobotics' intrinsic value may or may not be the same as its current market price of 95.59, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 95.59 | Real 64.67 | Target 46.38 | Hype 97.33 |
The intrinsic value of Procept Biorobotics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Procept Biorobotics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Procept Biorobotics Corp helps investors to forecast how Procept stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procept Biorobotics more accurately as focusing exclusively on Procept Biorobotics' fundamentals will not take into account other important factors: Procept Biorobotics Corp Company Current Valuation Analysis
Procept Biorobotics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Procept Biorobotics Current Valuation | 5.15 B |
Most of Procept Biorobotics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procept Biorobotics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Procept Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Procept Biorobotics is extremely important. It helps to project a fair market value of Procept Stock properly, considering its historical fundamentals such as Current Valuation. Since Procept Biorobotics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Procept Biorobotics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Procept Biorobotics' interrelated accounts and indicators.
Click cells to compare fundamentals
Procept Current Valuation Historical Pattern
Today, most investors in Procept Biorobotics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Procept Biorobotics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Procept Biorobotics current valuation as a starting point in their analysis.
Procept Biorobotics Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Procept Biorobotics Corp has a Current Valuation of 5.15 B. This is 64.16% lower than that of the Health Care Equipment & Supplies sector and 58.56% lower than that of the Health Care industry. The current valuation for all United States stocks is 69.03% higher than that of the company.
Procept Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procept Biorobotics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Procept Biorobotics could also be used in its relative valuation, which is a method of valuing Procept Biorobotics by comparing valuation metrics of similar companies.Procept Biorobotics is currently under evaluation in current valuation category among its peers.
Procept Biorobotics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Procept Biorobotics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Procept Biorobotics' managers, analysts, and investors.Environmental | Governance | Social |
Procept Fundamentals
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 5.15 B | ||||
| Shares Outstanding | 54.11 M | ||||
| Shares Owned By Insiders | 4.60 % | ||||
| Shares Owned By Institutions | 86.33 % | ||||
| Number Of Shares Shorted | 6.37 M | ||||
| Price To Book | 21.82 X | ||||
| Price To Sales | 26.34 X | ||||
| Revenue | 136.19 M | ||||
| Gross Profit | 37.09 M | ||||
| EBITDA | (98.09 M) | ||||
| Net Income | (105.9 M) | ||||
| Cash And Equivalents | 269.81 M | ||||
| Cash Per Share | 6.05 X | ||||
| Total Debt | 79.2 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 16.01 X | ||||
| Book Value Per Share | 4.63 X | ||||
| Cash Flow From Operations | (108 M) | ||||
| Short Ratio | 5.40 X | ||||
| Earnings Per Share | (1.95) X | ||||
| Price To Earnings To Growth | (0.47) X | ||||
| Target Price | 100.83 | ||||
| Number Of Employees | 626 | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 5.26 B | ||||
| Total Asset | 404.72 M | ||||
| Retained Earnings | (454.57 M) | ||||
| Working Capital | 304.64 M | ||||
| Net Asset | 404.72 M |
About Procept Biorobotics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Procept Biorobotics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procept Biorobotics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procept Biorobotics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.